Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Boehringer Ingelheim discloses SYK inhibitors

Oct. 5, 2015

Beijing Hanmi divulges ROR-gamma receptor antagonists

Oct. 5, 2015

Bayer presents new soluble guanylate cyclase activators

Oct. 2, 2015

Boehringer Ingelheim presents SYK inhibitors

Oct. 2, 2015

reMYND presents compounds for protein-misfolding disorders

Oct. 2, 2015

Roche and Siena Biotech report BACE1 inhibitors

Oct. 2, 2015

Merck & Co. presents SYK inhibitors

Oct. 1, 2015

iTeos Therapeutics describes TDO2 inhibitors

Oct. 1, 2015

reMYND develops new compounds for protein-misfolding disorders

Oct. 1, 2015

Merck & Co. and Merck Frosst Canada report HIV protease inhibitors

Sep. 30, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...